Format

Send to

Choose Destination
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):122-123. doi: 10.1093/ehjcvp/pvz005.

Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy.

Author information

1
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
2
Department of Cardiology, Oslo University Hospital Ullevaal, Kirkeveien 166, Oslo, Norway.
3
Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
4
Department of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia.
PMID:
30698668
DOI:
10.1093/ehjcvp/pvz005

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for Norwegian BIBSYS system
Loading ...
Support Center